CNTNAP2 and autoimmune disease: In summary, our data reveal key aspects of the therapeutically-tractable immunobiology and neurobiology underlying CASPR2-Ab-E and present a novel roadmap to systematically dissect how sequential, comparative studies of autoantigen-specific B cell inform our understanding of how and where immunological tolerance is lost in human autoimmune diseases.